Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -307.40x is 641% below its 5-year average of 56.77x, around the middle of its 5-year range (-1050.00x–901.67x).
42.70% above its 12-month average of -536.44x.
Reported quarterly interest coverage; no daily interpolation.
INTEREST COVERAGE RATIO
-307.40x
INTEREST COVERAGE RATIO AVG TTM
-536.44x
INTEREST COVERAGE RATIO AVG 3Y
-123.08x
INTEREST COVERAGE RATIO AVG 5Y
56.77x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+42.70%
CURRENT VS 3Y AVG
-149.77%
CURRENT VS 5Y AVG
-641.45%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
6.88x
median of 82 covered companies
CURRENT VS SECTOR MEDIAN
-4564.78%
vs the sector median at left
Moderna, Inc.
Market Cap
$54.93B
Interest Coverage Ratio
-307.40x
TTM Avg
-536.44x
3Y Avg
-123.08x
5Y Avg
56.77x
Market Cap
$56.04B
Interest Coverage Ratio
7.51x
TTM Avg
9.04x
3Y Avg
12.85x
5Y Avg
10.81x
Market Cap
$49.72B
Interest Coverage Ratio
N/A
TTM Avg
75.36x
3Y Avg
70.16x
5Y Avg
63.82x
Market Cap
$49.59B
Interest Coverage Ratio
4.21x
TTM Avg
4.38x
3Y Avg
4.79x
5Y Avg
4.28x
Market Cap
$48.23B
Interest Coverage Ratio
2.30x
TTM Avg
2.38x
3Y Avg
5.10x
5Y Avg
7.90x
Market Cap
$63.25B
Interest Coverage Ratio
8.69x
TTM Avg
10.46x
3Y Avg
10.41x
5Y Avg
11.51x
Market Cap
$42.57B
Interest Coverage Ratio
2.35x
TTM Avg
2.35x
3Y Avg
1.39x
5Y Avg
1.57x
Market Cap
$67.36B
Interest Coverage Ratio
11.38x
TTM Avg
9.10x
3Y Avg
7.54x
5Y Avg
6.16x
Market Cap
$42.14B
Interest Coverage Ratio
3.14x
TTM Avg
3.21x
3Y Avg
3.42x
5Y Avg
3.19x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Moderna, Inc. (MRNA) | $54.93B | -307.40x | -536.44x | -123.08x | 56.77x |
| Cardinal Health, Inc. (CAH)vs › | $56.04B | 7.51x | 9.04x | 12.85x | 10.81x |
| Edwards Lifesciences Corporation (EW)vs › | $49.72B | N/A | 75.36x | 70.16x | 63.82x |
| Becton, Dickinson and Company (BDX)vs › | $49.59B | 4.21x | 4.38x | 4.79x | 4.28x |
| Humana Inc. (HUM)vs › | $48.23B | 2.30x | 2.38x | 5.10x | 7.90x |
| Cencora, Inc. (COR)vs › | $63.25B | 8.69x | 10.46x | 10.41x | 11.51x |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $42.57B | 2.35x | 2.35x | 1.39x | 1.57x |
| Boston Scientific Corporation (BSX)vs › | $67.36B | 11.38x | 9.10x | 7.54x | 6.16x |
| IQVIA Holdings Inc. (IQV)vs › | $42.14B | 3.14x | 3.21x | 3.42x | 3.19x |
| Agilent Technologies, Inc. (A)vs › | $41.05B | 13.21x | 14.36x | 15.54x | 14.94x |
Interest Coverage
-307.4x
Debt/Equity
0.19
Current Ratio
2.29
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | -81.65x |
| 2025-12-31 | -107.13x |
| 2025-06-30 | -907.00x |
| 2025-03-31 | -1050.00x |
| 2024-12-31 | -207.67x |
| 2024-09-30 | -11.67x |
| 2024-06-30 | -227.17x |
| 2024-03-31 | -211.00x |
| 2023-12-31 | 1.00x |
| 2023-09-30 | -201.20x |
| 2023-06-30 | -143.62x |
| 2023-03-31 | -40.67x |
| 2022-12-31 | 158.00x |
| 2022-09-30 | 145.75x |
| 2022-06-30 | 489.40x |
| 2022-03-31 | 704.50x |
| 2021-12-31 | 901.67x |
| 2021-09-30 | 889.50x |
| 2021-06-30 | 612.40x |
| 2021-03-31 | 422.00x |
| 2020-12-31 | -78.40x |
| 2020-09-30 | -82.96x |
| 2020-06-30 | -65.03x |
| 2020-03-31 | -78.55x |
| 2019-12-31 | -65.44x |
| 2019-09-30 | -78.92x |
| 2019-06-30 | -81.42x |
| 2019-03-31 | -92.39x |
| 2018-12-31 | -100.35x |
| 2018-03-31 | -2866.74x |
